iNtRON Biotechnology, Inc. was founded in 1999 to address growing problems in the control
and treatment of disease-causing bacteria and viruses.

These problems are presently compounded by public and governmental reluctance to employ
new and potentially hazardous chemical agents or solutions born of recombinant technology.

iNtRON is using its core bacteriophage and virus technology to develop novel and natural
products for use in food processing, environmental clean-up, sanitation, consumer products,
and problems of antibiotic resistance in animal and human health therapy.

I believe you'll find that iNtRON is a dynamic and a technical competitive enterprise.
As an emerging biopharmaceutical company,  iNtRON is in the unique position of having
a promising candidate product pipeline and an effective and experienced R&D team to
realize new products and new  businesses.

Today, more than ever, the combined efforts of motivated, dedicated and skilled people
working seamlessly together are needed to competitively develop, launch and sustain
new drugs on the World market.

I fervently believe that we have such a team and work environment at iNtRON.

Come explore our IR and learn more about us.